Les informations fournies sur EL7.AI sont uniquement à des fins éducatives et informatives et ne constituent pas un conseil financier.

Urgentstocks

Cingulate Inc Shares Surge Following Key Patent Approval for ADHD Treatment

Détecté pour la première fois: Mar 16, 2026, 5:47 PM

Dernière mise à jour: 8 days ago

8 articles·8 articles

Instruments affectés

CING

Résumé de l'événement

On March 16, the US Patent and Trademark Office (USPTO) approved a key patent application for Cingulate Inc's ADHD treatment. The patent protects the proprietary technology behind CTx-1301, the company's lead ADHD drug candidate. Following the announcement, Cingulate Inc shares surged in Monday morning trading.

Chronologie

Ciena Shares Surge as Analyst Upgrades Highlight Oracle Data Center Synergy

Mar 23, 2026, 10:31 PMImpact: 6

Sharp 8% Drop in Oil Prices Boosts Carvana Stock Performance

Mar 23, 2026, 8:04 PMImpact: 7

Planet Labs Shares Surge 15% on Record Earnings and AI-Driven Growth Outlook

Mar 20, 2026, 9:01 AMImpact: 6

Cingulate Inc Shares Surge Following Key Patent Approval for ADHD Treatment

Mar 16, 2026, 5:47 PMImpact: 7